Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
VALIANT LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) -96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -96.81 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹469.6 Cr -0.1% -6.1% -17.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹375,100.0 Cr -5.6% -9.9% -12.1% Stock Analytics
DIVIS LABORATORIES ₹161,698.0 Cr -2.5% -8.4% 21.7% Stock Analytics
CIPLA ₹128,239.0 Cr -0.8% 1.8% -1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,216.0 Cr -2.4% -4% 4.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,855.0 Cr -0.3% -0.9% -9.7% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-0.1%

-6.1%

-17.8%

SENSEX

-1.2%

-1.2%

-1.7%


You may also like the below Video Courses